Medtronic
MDT
2,184 hedge funds and large institutions have $104B invested in Medtronic in 2025 Q3 according to their latest regulatory filings, with 193 funds opening new positions, 922 increasing their positions, 818 reducing their positions, and 127 closing their positions.
52% more first-time investments, than exits
New positions opened: 193 | Existing positions closed: 127
44% more call options, than puts
Call options by funds: $924M | Put options by funds: $641M
22% more funds holding in top 10
Funds holding in top 10: 32 → 39 (+7)
15% more capital inflows, than outflows
Capital inflows: $6.83B | Capital outflows: $5.92B
13% more repeat investments, than reductions
Existing positions increased: 922 | Existing positions reduced: 818
2% more funds holding
Funds holding: 2,149 → 2,184 (+35)
0.61% more ownership
Funds ownership: 84.57% → 85.17% (+0.61%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$1.57B |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$505M |
| 3 |
Barclays
London,
United Kingdom
|
+$321M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$304M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$285M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$871M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$560M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$521M |
| 4 |
Pzena Investment Management
New York
|
-$269M |
| 5 |
BlackRock
New York
|
-$265M |
MDT Hedge Fund Activity: Q3 2025 in Review
2,184 of the 7,661 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q3 2025, worth a combined $104B — up 10% from $94.6B a quarter earlier.
Buyers outnumbered sellers: 193 funds opened new MDT positions and 127 closed out — a net gain of 66 holders — while 922 added to existing stakes and 818 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $1.57B. The largest seller was Goldman Sachs, cutting an estimated $871M.
- 2,184 institutional investors held Medtronic (MDT) as of Q3 2025, up from 2,149 in Q2 2025.
- Funds reported $104B of Medtronic stock for Q3 2025, up 10% quarter-over-quarter.
- 193 funds opened new Medtronic positions in Q3 2025 and 127 closed out, a net change of +66 holders.
- The largest Medtronic buyer in Q3 2025 was JP Morgan Chase, an estimated $1.57B added.
- The largest Medtronic seller in Q3 2025 was Goldman Sachs, an estimated $871M sold.
Based on aggregated 13F filings for Q3 2025.